Phreesia Analysts Raise Their Forecasts After Q2 Results

Financial Performance - Phreesia reported quarterly earnings of 1 cent per share, exceeding market estimates of a loss of 6 cents per share [1] - Quarterly sales reached $117.255 million, slightly above expectations of $116.526 million [1] - The company affirmed its FY2026 sales guidance of $472 million to $482 million, compared to market estimates of $477.148 million [1] Strategic Developments - The CEO announced the achievement of the company's first-ever net income positive quarter and highlighted the expansion of reach and capabilities [2] - Phreesia entered into a definitive agreement to acquire AccessOne, a leader in healthcare receivables financing solutions [2] Market Reaction - Following the earnings announcement, Phreesia shares fell 8.5% to trade at $28.59 [3] - Analysts adjusted their price targets for Phreesia, with Needham raising it from $29 to $35, Piper Sandler from $33 to $34, and Canaccord Genuity from $34 to $38 [8]